Veracyte, Inc. Share Price & Technical Analysis
VCYT · $45.03 (-0.35%)
Healthcare / Diagnostics & Research
$45.03
-0.35%
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test …
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
36% return in May, 3% avg return in past 3 year May month.
15% return in 2026, 31% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | -4% | -9% | 2% | 36% | – | – | – | – | – | – | – | 15% |
| 25 | 13% | -21% | -15% | 3% | -13% | 2% | -12% | 31% | 14% | 5% | 31% | -10% | 28% |
| 24 | -8% | -7% | -6% | -11% | 6% | 2% | 11% | 30% | 9% | 0% | 26% | -8% | 44% |
| 23 | 3% | -3% | -9% | 2% | 15% | -1% | 8% | -3% | -17% | -7% | 24% | 8% | 20% |
| 22 | -27% | -10% | -1% | -26% | -14% | 12% | 32% | -22% | -17% | 18% | 34% | -15% | -36% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Strong · Strong
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$3.15B
P/E ratio
36.55
52W high
$50.71
52W low
$22.61
Volume
13,98,669
Beta
1.89
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Veracyte, Inc. share price today?
- Veracyte, Inc. (VCYT) last traded around $45.03 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does VCYT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for VCYT. Download the app for real-time alerts.
- How can I analyze Veracyte, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.